http://purl.org/np/RAgU_gBcYN... RAgU_gBcYN

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/1999/02/22-rdf-syntax-ns#type type

http://pubannotation.org/ontology/tao.owl#document_text document_text

(unknown)

2023-02-27T16:53:35.642Z

http://purl.org/np/RAgU_gBcYN... RAgU_gBcYN

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/2000/01/rdf-schema#seeAlso seeAlso

https://dailymed.nlm.nih.gov/d...f4-2829-423f-a595-dc09c9cc0e40 drugInfo.cfm?setid=bed3c03f4-2829-423f-a595-dc09c9cc0e40

(unknown)

2023-02-27T16:53:35.642Z

http://purl.org/np/RAgU_gBcYN... RAgU_gBcYN

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://pubannotation.org/ontology/tao.owl#has_value has_value

Dextroamphetamine sulfate tablets are indicated in: Narcolepsy and Attention Deficit Disorder with Hyperactivity: As an integral part of a total treatment program that typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in pediatric patients (ages 3 years to 16 years)

(unknown)

2023-02-27T16:53:35.642Z

http://purl.org/np/RAgU_gBcYN... RAgU_gBcYN

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://purl.org/np/RAgU_gBcYN...#_na8e63c0967774770aa886e0901005a8ab4 _na8e63c0967774770aa886e0901005a8ab4

http://pubannotation.org/ontology/tao.owl#part_of part_of

(unknown)

2023-02-27T16:53:35.642Z

http://purl.org/np/RAgU_gBcYN... RAgU_gBcYN

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://purl.org/np/RAgU_gBcYN...#_na8e63c0967774770aa886e0901005a8ab6 _na8e63c0967774770aa886e0901005a8ab6

http://pubannotation.org/ontology/tao.owl#part_of part_of

(unknown)

2023-02-27T16:53:35.642Z